METLIFE INC 8-K

What Happened
MetLife, Inc. (MET) filed a Form 8-K reporting the results of its annual meeting of common shareholders held June 16, 2026. Shareholders elected all eleven director nominees for terms expiring at the 2027 annual meeting, ratified Deloitte & Touche LLP as the company’s independent auditor for 2026, and approved—on an advisory (non‑binding) basis—the compensation of the company’s Named Executive Officers.

Key Details

• Date of meeting: June 16, 2026; Form 8-K filed June 22, 2026.
• Eleven directors elected (each for a one‑year term); examples of vote totals: Daniel S. Glaser — 548,594,293 for; Christian S. Mumenthaler, Ph.D. — 548,665,228 for. Broker non‑votes reported: 42,002,376.
• Ratification of auditor (Deloitte & Touche LLP): 557,226,053 for; 34,799,734 against; 275,234 abstained.
• Advisory (non‑binding) approval of executive compensation (say‑on‑pay): 519,208,384 for; 29,698,510 against; 1,391,751 abstained (42,002,376 broker non‑votes).

Why It Matters
Board elections and the auditor ratification confirm continuity of MetLife’s governance and financial reporting for 2026. The advisory approval of executive compensation signals shareholder acceptance of pay practices (though non‑binding), while the sizable broker non‑votes indicate a material block of shares not voted by brokers that can affect percentages reported. Investors watch these outcomes for governance stability and as context for future proxy and strategic decisions.